Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

NCI head Sharpless named as interim FDA chief

The search for a permanent replacement is still ongoing

- PMLiVE

NICE partially clears Darzalex combo in blood cancer

Approved in second-line use under  CDF

- PMLiVE

Brexit deal defeated again, crucial no-deal vote awaits

UK pharma urges no-deal to be ruled out

01000010 01101001 01101110 01100001 01110010 01111001

Success and failure is a binary outcome

- PMLiVE

Bedrock keep it in the family

Recent filming project really is a family affair

Bedrock Healthcare Communications

Graduation day is celebrated by Lucid’s third Futures Academy cohort

Lucid’s Futures Academy is proud to release its most recent cohort of graduates into the business for the first of their two rotations.The Futures Academy begins with an eight-week intensive...

Lucid Group Communications Limited

- PMLiVE

Trump budget targets rebates, out-of-pocket costs

Biotech sector welcomes end to rebates, but worries about Medicare cuts

- PMLiVE

Optimism on Orkambi in England as talks to resume

Scotland's deal puts pressure on NHS England and NICE

AstraZeneca AZ

AZ signs $20m deal with Seres for microbiome project

Shares in Seres shot up 25% after the deal was announced

- PMLiVE

23andMe to offer type 2 diabetes testing kit

New report is powered by data from the company’s customers

- PMLiVE

The Communiqué Awards: what are judges looking for?

Judges in the Communiqué Awards reveal how to bring creativity and strategic thinking together

Cuttsy+Cuttsy named one of the Best Places to Work 2019 by Campaign

11 March 2019—Cuttsy+Cuttsy are honoured and extremely proud to be named one of the 50 Best Places to Work in 2019 by Campaign. The results were announced on 6th March...

Cuttsy + Cuttsy

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links